Resultados globales: 4 registros encontrados en 0.02 segundos.
Artículos, Encontrados 4 registros
Artículos Encontrados 4 registros  
1.
11 p, 959.0 KB Outcome of liver cancer patients with SARS-CoV-2 infection : An International, Multicentre, Cohort Study / Muñoz-Martínez, S (Hospital Clínic i Provincial de Barcelona) ; Sapena, Victor (Hospital Clínic i Provincial de Barcelona) ; Forner, Alejandro (Hospital Clínic i Provincial de Barcelona) ; Bruix, Jordi (Hospital Clínic i Provincial de Barcelona) ; Sanduzzi Zamparelli, Marco (Hospital Clínic i Provincial de Barcelona) ; Ríos, José (Hospital Clínic i Provincial de Barcelona) ; Bouattour, Mohamed (Hôpital Beaujon) ; El-Kassas, Mohamed (Helwan University) ; Leal, Cassia R. G. (Hospital Federal do Servidores do Estado) ; Mocan, Tudor ("Octavian Fodor" Institute for Gastroenterology and Hepatology) ; Nault, Jean-Charles (Université de Paris) ; Alves, Rogerio C. P. (Bp Beneficência Portuguesa de São Paulo) ; Reeves, Helen L. (Newcastle University Translational and Clinical Research Institute) ; Da Fonseca, Leonardo G (University of Sao Paulo School of Medicine) ; García-Juárez, Ignacio (National Institute of Medical Sciences and Nutrition Salvador Zubirán) ; Pinato, David J. (Imperial College London) ; Varela Calvo, Maria (Hospital Universitario Central de Asturias) ; Alqahtani, Saleh A. (King Faisal Specialist Hospital & Research Center) ; Alvares-da-Silva, Mario R. (Universidade Federal do Rio Grande do Sul) ; Bandi, Juan C. (Hospital Italiano) ; Rimassa, Lorenza (Humanitas Cancer Center) ; Lozano, Mar (Hospital Universitario Infanta Leonor) ; González Santiago, Jesús M. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Tacke, Frank (Campus Virchow-Klinikum and Campus Charité Mitte) ; Sala, Margarita (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Anders, María (Hepatología) ; Lachenmayer, Anja (Bern University Hospital) ; Piñero, Federico (Hospital Universitario Austral) ; França, Alex (Federal University of Sergipe) ; Guarino, Maria (University of Naples Federico II) ; Elvevi, Alessandra (Bicocca School of Medicine) ; Cabibbo, Giuseppe (University of Palermo) ; Peck-Radosavljevic, Markus (Klinikum Klagenfurt am Wörthersee) ; Rojas, Ángela (Universidad de Sevilla) ; Vergara, Mercedes (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Braconi, Chiara (University of Glasgow) ; Pascual, Sonia (HGU Dr. Balmis) ; Perelló, Christie (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Mello, Vivianne (AMO CLINIC) ; Rodríguez-Lope, Carlos (IDIVAL) ; Acevedo, Juan (University Hospitals Plymouth NHS Trust (Regne Unit)) ; Villani, Rosanna (Department of Medical and Surgical Sciences) ; Hollande, Clemence (Hôpital Beaujon) ; Vilgrain, Valérie (Hôpital Beaujon) ; Tawheed, Ahmed (Helwan University) ; Ferguson Theodoro, Carmem (Universidade Federal Fluminense) ; Sparchez, Zeno (University of Medicine and Pharmacy) ; Blaise, Lorraine (Université de Paris) ; Viera-Alves, Daniele E. (Bp Beneficência Portuguesa de São Paulo) ; Watson, Robyn (Newcastle University Translational and Clinical Research Institute) ; Carrilho, Flair J. (University of Sao Paulo School of Medicine) ; Moctezuma-Velázquez, Carlos (National Institute of Medical Sciences and Nutrition Salvador Zubirán) ; D'Alessio, Antonio (Humanitas University) ; Iavarone, Massimo (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Reig, María (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population. [...]
2022 - 10.1111/liv.15320
Liver International, Vol. 42 (june 2022) , p. 1891-1901  
2.
9 p, 1.7 MB KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer / Sclafani, Francesco (The Royal Marsden NHS Foundation Trust) ; Chau, Ian (The Royal Marsden NHS Foundation Trust) ; Cunningham, David (The Royal Marsden NHS Foundation Trust) ; Hahne, Jens Claus (The Institute of Cancer Research) ; Vlachogiannis, George (The Institute of Cancer Research) ; Eltahir, Zakaria (The Royal Marsden NHS Foundation Trust) ; Lampis, Andrea (The Institute of Cancer Research) ; Braconi, Chiara (The Institute of Cancer Research) ; Kalaitzaki, Eleftheria (The Royal Marsden NHS Foundation Trust) ; De Castro, David Gonzalez (The Royal Marsden NHS Foundation Trust) ; Wotherspoon, Andrew (The Royal Marsden NHS Foundation Trust) ; Capdevila Castillón, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Glimelius, Bengt (University of Uppsala) ; Tarazona, Noelia (Universitat de València) ; Begum, Ruwaida (The Royal Marsden NHS Foundation Trust) ; Lote, Hazel (The Institute of Cancer Research) ; Hulkki Wilson, Sanna (The Royal Marsden NHS Foundation Trust) ; Mentrasti, Giulia (The Institute of Cancer Research) ; Brown, Gina (The Royal Marsden NHS Foundation Trust) ; Tait, Diana (The Royal Marsden NHS Foundation Trust) ; Oates, Jacqueline (The Royal Marsden NHS Foundation Trust) ; Valeri, Nicola (The Institute of Cancer Research) ; Universitat Autònoma de Barcelona
There are limited data on circulating, cell-free, tumour (ct)DNA analysis in locally advanced rectal cancer (LARC). Digital droplet (dd)PCR was used to investigate KRAS/BRAF mutations in ctDNA from baseline blood samples of 97 LARC patients who were treated with CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX ± cetuximab in a randomised phase II trial. [...]
2018 - 10.1038/s41598-018-19212-5
Scientific reports, Vol. 8 (january 2018)  
3.
6 p, 1.4 MB Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients / Sclafani, Francesco (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Chau, Ian (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Cunningham, David (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Lampis, Andrea (The Institute of Cancer Research. Department of Molecular Pathology) ; Hahne, Jens Claus (The Institute of Cancer Research. Department of Molecular Pathology) ; Ghidini, Michele (The Institute of Cancer Research. Department of Molecular Pathology) ; Lote, Hazel (The Institute of Cancer Research. Department of Molecular Pathology) ; Zito, Domenico (The Institute of Cancer Research. Department of Molecular Pathology) ; Tabernero, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Glimelius, Bengt (University of Uppsala. Genetics and Pathology, Experimental and Clinical Oncology. Department of Immunology) ; Cervantes, Andrés (University of Valencia. Biomedical Research Institute INCLIVA. Department of Haematology and Medical Oncology) ; Begum, Ruwaida (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; De Castro, David Gonzalez (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Wilson, Sanna Hulkki (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Peckitt, Clare (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Eltahir, Zakaria (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Wotherspoon, Andrew (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Tait, Diana (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Brown, Gina (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Oates, Jacqueline (The Royal Marsden NHS Foundation Trust. Department of Medicine) ; Braconi, Chiara (The Institute of Cancer Research. Department of Cancer Therapeutics) ; Valeri, Nicola (The Institute of Cancer Research. Department of Molecular Pathology) ; Universitat Autònoma de Barcelona
Analysis of a polymorphism in mature microRNA-608 (rs4919510) in rectal cancer patients enrolled in a randomized phase II clinical trial identified patient subpopulations who might benefit from the use of an intensified neo-adjuvant treatment strategy with Cetuximab. [...]
2016 - 10.1093/carcin/bgw073
Carcinogenesis, Vol. 37 (july 2016) , p. 852-857  
4.
6 p, 225.1 KB Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer : results of the EXPERT-C trial / Sclafani, Francesco (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Chau, Ian (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Cunningham, David (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Peckitt, C. (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Lampis, Andrea (The Institute of Cancer Research. Division of Molecular Pathology (UK)) ; Hahne, Jens Claus (The Institute of Cancer Research. Division of Molecular Pathology (UK)) ; Braconi, Chiara (The Institute of Cancer Research. Division of Cancer Therapeutics (UK)) ; Tabernero, Josep (Hospital Universitari Vall d'Hebron) ; Glimelius, B. (University of Uppsala. Department of Immunology, Genetics and Pathology (Sweden)) ; Cervantes, Andrés (Universitat de València. Departament d'Hematologia i Oncologia Mèdica) ; Begum, Ruwaida (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; González De Castro, David (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Hulkki Wilson, Sanna (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Eltahir, Zakaria (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Wotherspoon, Andrew (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Tait, D. (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Brown, Gina (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Oates, J. (The Royal Marsden NHS Foundation Trust. Department of Medicine (UK)) ; Valeri, Nicola (The Institute of Cancer Research. Division of Molecular Pathology (UK)) ; Universitat Autònoma de Barcelona
Lethal-7 (let-7) is a tumour suppressor miRNA which acts by down-regulating several oncogenes including KRAS. A single-nucleotide polymorphism (rs61764370, T > G base substitution) in the let-7 complementary site 6 (LCS-6) of KRAS mRNA has been shown to predict prognosis in early-stage colorectal cancer (CRC) and benefit from anti-epidermal growth factor receptor monoclonal antibodies in metastatic CRC. [...]
2015 - 10.1093/annonc/mdv285
Annals of oncology, Vol. 26, Issue 9 (September 2015) , p. 1936-1941  

Vea también: autores con nombres similares
5 Braconi, Chiara
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.